IO Biotech探索战略替代方案

2026-01-21 18:37

IO Biotech (IOBT) plans to explore a range of strategic alternatives, including a merger, a business combination, a sale of assets, or a liquidation and dissolution, to maximize stockholder value.
The company is also evaluating a further reduction-in-force and other efforts to significantly reduce its operating expenses.
No timetable has been established for the completion of this process, and the company does not expect to disclose developments unless and until the board of directors has concluded that disclosure is appropriate or required.
IOBT -3.2% premarket to $0.5
Source: Press Release

More on IO Biotech